• slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1

Indo-French Liver & Metabolic Disease Network (InFLiMeN)

Ministry of Science & Technology, Government of India and Ministry for Europe & Foreign Affairs, Government of France
Indo-French Centre for the Promotion of Advanced Research (IFCPAR / CEFIPRA)

Liver Disease

The liver is the body's primary metabolic hub and performs numerous functions including detoxification, synthesis, secretion, immunity, and excretion. Despite its remarkable regenerative capacity, it remains vulnerable to viral infections, unhealthy dietary habits, obesity, and alcohol abuse.

Hepatitis B and C infections can lead to chronic inflammation, cirrhosis, and liver cancer. Additionally, sedentary lifestyles and high-fat diets contribute significantly to Non-Alcoholic Fatty Liver Disease (NAFLD), which has become a major global health concern.

Liver Disease Burden in India and France

Liver disease is a significant public health challenge in both India and France. In India, viral hepatitis and the increasing prevalence of NAFLD are major contributors. India is also the first country to formally integrate NAFLD into its National Programme for Prevention and Control of Non-Communicable Diseases.

In France, alcohol-related liver disease and metabolic disorders remain important concerns. Growing obesity and lifestyle changes are increasing the prevalence of fatty liver disease in both countries.

This shared health burden has strengthened Indo-French research collaboration in liver inflammation, diagnostics, drug discovery, vaccine development, and advanced therapeutic interventions.

14.6% - 42%

NAFLD Prevalence in India

23.6%

Expected NAFLD Prevalence in France by 2030

About InFLiMeN

Indo-French Collaboration
InFLiMeN Network

The Indo-French Liver and Metabolic Disease Network (InFLiMeN) is a collaborative initiative between India and France dedicated to advancing research, innovation, and capacity building in liver and metabolic diseases. The programme is supported by the Department of Science and Technology, Government of India, and the Ministry of Europe and Foreign Affairs, Government of France.

Through the support of IFCPAR/CEFIPRA, the network promotes bilateral scientific cooperation by facilitating joint research projects, collaborative grants, workshops, training programmes, and networking opportunities for scientists and healthcare professionals from both countries.

Bringing together leading researchers, clinicians, and innovators from India and France to accelerate discoveries and develop solutions for liver and metabolic diseases.

InFLiMeN aims to create a vibrant ecosystem that nurtures scientific exchange, translational research, technology development, and academic partnerships. Serving as a virtual knowledge hub, the network seeks to improve diagnosis, prevention, and treatment strategies while fostering innovation that benefits patients worldwide.


Objectives





  • Setting-up of goals, creation of teams

  • Submission of collaborative grant proposals

  • Industry - academia partnerships

  • Student - faculty exchange & training programs

  • Technology & innovation hubs

French Experts

Indian Experts

Meet Our Coordinators

Suggestion & Join us

Join us !